Name

Poly-Med

Legal name

Poly-Med Incorporated

Website

https://poly-med.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Medical Device Contract Manufacturing

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Miscellaneous Plastics Products (3080)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

akta.pro secondary industries

Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG), Polymer Filaments (FDM/FFF) (IMAAABAA), Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom) (IMANAFAC)

Keywords

• Bioresorbable polymers
• Absorbable medical devices
• Contract manufacturing
• Medical textiles
• Electrospinning services

Headquarters

HQ city

Anderson

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Contract Development & Manufacturing (CDMO Services): Full-service CDMO providing design, development, and manufacturing of custom absorbable medical devices. Services include design verification, analytical testing, and quality management. Revenue generated through project-based contracts and manufacturing agreements with medical device companies.
2. Bioresorbable Polymer Sales: Sale of raw absorbable polymers including Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, Aquaprene®, Strataprene®, and Caproprene® product families. Polymers sold for conversion via injection molding, extrusion, electrospinning, and 3D printing.
3. 3D Printing Materials: Sale of medical-grade 3D printing filaments (Lactoprene® 100M, Dioxaprene® 100M, Max-Prene® 955, etc.) and Photoset® resins for additive manufacturing of medical devices.
4. Analytical Testing Services: In-house analytical capabilities including inherent viscosity measurements, differential scanning calorimetry, gas chromatography, gel permeation chromatography, in-vitro degradation studies, and custom test method development.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Core offering

Poly-Med is a vertically integrated Contract Development & Manufacturing Organization (CDMO) that designs, develops, and manufactures custom absorbable medical implants and bioresorbable polymers for medical device and pharmaceutical companies. Its offerings span proprietary branded polymer families (Max-Prene®, Dioxaprene®, Lactoprene®, Glycoprene®, etc.), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles, medical-grade electrospinning for nanofibrous scaffolds, and 3D printing (filament-based FFF and resin-based SLA/DLP) — supported by design, development, analytical testing, and ISO 13485 certified manufacturing services.

Product overview

Poly-Med is a Contract Development & Manufacturing Organization (CDMO) specializing in bioresorbable/ absorbable medical devices. Their vertically integrated platform spans from polymer synthesis to finished medical device manufacturing. Core offerings include: bioresorbable polymers (Max-Prene®, Dioxaprene®, Lactoprene®, Strataprene®, Caproprene®, Glycoprene® families), bioresorbable extrusions (monofilament fibers, multifilament yarns, films), biomedical textiles (knitted and braided constructs), electrospinning services for nanofibrous scaffolds, and 3D printing (both filament-based FFF and resin-based SLA/DLP). Services include design & development, vertically integrated manufacturing, and analytical testing. The company holds ISO 13485 certification and operates cGMP-compliant facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioresorbable Polymers Medical-grade absorbable polymers including Max-Prene®, Dioxaprene®, Lactoprene®, Strataprene®, Caproprene™, Glycoprene®, and Aquaprene® polymer families for use in implantable medical devices. These polymers transform the healing process by temporarily restoring functionality in targeted areas and resorb within the body without a trace, minimizing the need for follow-up surgical procedures.
• Bioresorbable Extrusions Polymers extruded into monofilament fibers, multifilament yarns, or films as inputs into biomedical textile applications, allowing customers to select the filament for their design rather than designing for an existing filament.
• Biomedical Textiles Custom medical-grade textiles including warp knit, weft knit, and braided constructs for implantable medical devices, with polymers selected to enable more responsive designs and better patient outcomes.
• Electrospinning Medical-grade electrospinning services producing nanofibrous scaffolds for tissue engineering and regenerative medicine applications, using electrostatic fiber fabrication to draw charged polymer solutions into submicron-scale fiber diameters that mimic native tissue properties.
• 3D Printing Additive manufacturing services using filament-based (FFF) and resin-based (SLA/DLP) approaches to create lattice-based architectures with bioresorbable implants inaccessible via injection molding.
• Photoset® Resin First-in-class bioresorbable fast-degrading resins for photopolymerization 3D printing methods including SLA, DLP, and two-photon polymerization, utilizing monomeric constituents used in medical devices for over 40 years.
• Max-Prene® 955 Custom 95/5 poly(glycolide-co-lactide) copolymer with high tensile modulus and faster degradation profile; exhibits strength loss in 1-4 weeks with complete mass loss in approximately 6 months.
• Dioxaprene® 100M 100% polydioxanone (PDO) linear homopolymer with lower initial modulus, extended strength retention, and increased flexibility; maintains strength for 4-6 weeks with complete mass loss in approximately 9 months.
• Lactoprene® 100M

Quantifiable outcome

• Absorbable implants that resorb within the body without a trace, minimizing the need for follow-up surgical procedures
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• The SiMT (Southeastern Institute of Manufacturing & Technology)minorStrategic or Co-development Partner · 4 August 2017Partnership with The SiMT in Florence, SC for additive manufacturing experimentation. Poly-Med 3D printing team toured facilities including advanced machining center, listening center, and additive manufacturing center. Potential for SiMT to experiment with Poly-Mel's materials.
• Resorbable Devices ABcoreStrategic or Co-development PartnerSwedish company developing the LigaTie® resorbable ligation device using Poly-Mel's Glycoprene® polymers. The device addresses challenges in surgical ligation procedures, restricting blood flow and preventing blood loss and air leaks. Poly-Med supports material development of novel flexible, fast-degrading absorbable polymer meeting the device's demanding specifications. Successful veterinary applications include canine neutering, lung lobectomy, and tissue sealing procedures.
• Queensland University of TechnologycoreStrategic or Co-development PartnerResearch collaboration with QUT (Mina Mohseni, Professor Dietmar Hutmacher, Dr. Nathan Castro) to promote research on Poly-Mel's unique bioresorbable medical grade 3D printing filaments. Research characterized material properties and evaluated potential use in both hard and soft tissue engineering applications. Publication in MDPI journal evaluated Lactoprene® 100M, Max-Prene® 955, Dioxaprene® 100M, and Caproprene™ 100M filaments in fused filament fabrication tissue scaffolding.
• SCBIOcoreStrategic or Co-development PartnerSouth Carolina's life sciences industry association. Poly-Med represented on SCBIO Board of Directors. SCBIO describes Poly-Mel's platform technology, innovation, and dynamic research as resulting in leading edge products benefiting top medical device and pharmaceutical companies.
• MADE in South CarolinaminorStrategic or Co-development Partner$20 million NSF EPSCoR-funded initiative (Materials Assembly and Design Excellence) involving 10 universities across South Carolina. Poly-Med listed as a corporate partner among AVX, BMW, Boeing, GE, IBM, Michelin, and Milliken. Program aims to discover sustainable approaches for design and assembly of advanced materials serving STEM research, education, and workforce needs.
• ASTM InternationalcoreStrategic or Co-development PartnerActive participation in ASTM Committee F04 (Medical and Surgical Materials and Devices) and F42 (Additive Manufacturing). Poly-Mel's CTO Dr. Scott Taylor organized and chaired ASTM workshop on use of absorbable polymers for medical devices. Company working in F04.11 group to develop new standard for Polydioxanone resin.
• Advanced Regenerative Manufacturing Institute (ARMI)minorStrategic or Co-development PartnerCo-organized ASTM Workshop on Characterization of Fiber-based Scaffolds and Devices hosted by ARMI in Manchester, NH. Workshop featured seminar discussions from academia, clinicians, and industrial spotlights on emerging technologies and application of fiber-based scaffolds.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Teleflex Medical OEM: Large medical device OEM and contract manufacturer with absorbable suture and bioresorbable product lines. Competes with Poly-Med both as a buyer of absorbable polymers (in some cases) and as an integrated developer of absorbable implants in overlapping indications.
• Corbion: Dutch ingredients company producing PURAC® lactide and glycolide monomers used as the building blocks for bioresorbable polymers. Operates upstream of Poly-Med in the absorbable value chain but increasingly downstream through partnerships and is a key competitive force in medical-grade lactide supply.
• Ashland: Global specialty chemicals company with pharmaceutical and medical polymer offerings used in controlled-release and implantable applications. A broader incumbent competing for medical-grade polymer and CDMO-adjacent business.
• DSM Biomedical (now part of dsm-firmenich / Danaher legacy): Major biomedical materials business with a deep portfolio in bioresorbable polymers, UHMWPE, and coatings used in orthopedic, cardiovascular, and general surgery devices. Competes with Poly-Med on absorbable polymers and broader CDMO-adjacent material supply.

Emerging players

• TissueGen: Developer of biodegradable polymers for drug-eluting fibers, textile scaffolds, and implantable devices. Smaller and more research-oriented, but a credible emerging peer in the absorbable polymer and medical textile space where Poly-Med competes.
• Bezwada Biomedical: R&D-focused supplier of functional absorbable polymers and custom synthesis for medical device applications. Comparable to Poly-Med's custom polymer synthesis business and a direct peer in specialty absorbable chemistry development.

Direct peers

• Evonik: Global specialty chemicals company selling the Resomer® line of bioresorbable polymers (PLA, PLGA, PCL, PDO) for medical devices and parenteral drug delivery. Most direct competitor to Poly-Med's branded polymer families and a benchmark for scale in absorbable polymer supply.
• Zeus Industrial Products: Specialty manufacturer of polymer extrusions, tubing, and fiber components for medical devices including absorbable and biomaterial applications. Directly comparable to Poly-Med's bioresorbable extrusion and biomedical textile capabilities.
• Foster Corporation: Specialty compounder and supplier of medical-grade polymer materials including bioresorbable and radiopaque compounds for implantable devices. Competes with Poly-Med on custom polymer supply for downstream medical device manufacturers.
• Secant Group: US-based biomedical textile and implantable component manufacturer producing woven, knit, and braided structures including bioresorbable scaffolds. Directly competes with Poly-Med's biomedical textile and electrospinning offerings for regenerative and tissue engineering customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/PolyMedInc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Poly-Med